RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+15.79%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$280M
AUM Growth
–
Cap. Flow
+$280M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
44.86%
Holding
69
New
69
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Gilead Sciences
GILD
|
$21.4M |
| 2 |
Health Care Select Sector SPDR Fund
XLV
|
$20.5M |
| 3 |
Biogen
BIIB
|
$14.8M |
| 4 |
AbbVie
ABBV
|
$11.9M |
| 5 |
CELG
Celgene Corp
CELG
|
$10.5M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 72.98% |
| 2 | Financials | 1.53% |
| 3 | Industrials | 0.94% |
| 4 | Technology | 0.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Gilead Sciences
GILD
$140B
| $21.4M | 7.65% | +285,000 | New | +$21.4M |
|
|
2
Health Care Select Sector SPDR Fund
XLV
$33.9B
| $20.5M | 7.33% | +370,000 | New | +$20.5M |
|
|
3
Biogen
BIIB
$19.4B
| $14.8M | 5.3% | +53,000 | New | +$14.8M |
|
|
4
AbbVie
ABBV
$372B
| $11.9M | 4.24% | +225,000 | New | +$11.9M |
|
|
CELG
5
DELISTED
Celgene Corp
CELG
| $10.5M | 3.74% | +62,000 | New | +$10.5M |
|
6
McKesson
MCK
$85.4B
| $10.2M | 3.63% | +63,000 | New | +$10.2M |
|
|
THOR
7
DELISTED
THORATEC CORPORATION
THOR
| $10.1M | 3.6% | +275,000 | New | +$10.1M |
|
8
Bristol-Myers Squibb
BMY
$96B
| $9.59M | 3.43% | +180,500 | New | +$9.59M |
|
9
Amgen
AMGN
$155B
| $9.02M | 3.22% | +79,000 | New | +$9.02M |
|
10
Agilent Technologies
A
$35.7B
| $7.61M | 2.72% | +133,000 | New | +$7.61M |
|
11
UnitedHealth
UNH
$281B
| $7.53M | 2.69% | +100,000 | New | +$7.53M |
|
12
Thermo Fisher Scientific
TMO
$186B
| $7.52M | 2.69% | +67,500 | New | +$7.52M |
|
|
GENT
13
DELISTED
GENTIUM SPA ADS
GENT
| $6.82M | 2.44% | +119,500 | New | +$6.82M |
|
|
ALXN
14
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $6.79M | 2.42% | +51,000 | New | +$6.79M |
|
15
Intuitive Surgical
ISRG
$170B
| $6.72M | 2.4% | +17,500 | New | +$6.72M |
|
16
Illumina
ILMN
$15.8B
| $6.11M | 2.18% | +55,250 | New | +$6.11M |
|
17
Bausch Health
BHC
$2.74B
| $5.52M | 1.97% | +47,000 | New | +$5.52M |
|
|
TMH
18
DELISTED
Team Health Holdings Inc
TMH
| $5.35M | 1.91% | +117,500 | New | +$5.35M |
|
19
Cardinal Health
CAH
$35.5B
| $4.28M | 1.53% | +64,000 | New | +$4.28M |
|
|
AET
20
DELISTED
Aetna Inc
AET
| $4.27M | 1.53% | +62,300 | New | +$4.27M |
|
|
AGN
21
DELISTED
Allergan plc
AGN
| $4.12M | 1.47% | +24,500 | New | +$4.12M |
|
22
CVS Health
CVS
$92.8B
| $3.92M | 1.4% | +54,750 | New | +$3.92M |
|
|
WBA
23
DELISTED
Walgreens Boots Alliance
WBA
| $3.68M | 1.31% | +64,000 | New | +$3.68M |
|
24
Humana
HUM
$36.5B
| $3.41M | 1.22% | +33,000 | New | +$3.41M |
|
25
Puma Biotechnology
PBYI
$254M
| $3.26M | 1.17% | +31,500 | New | +$3.26M |
|